These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33492181)

  • 41. Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations.
    Pimparade MB; Morott JT; Park JB; Kulkarni VI; Majumdar S; Murthy SN; Lian Z; Pinto E; Bi V; Durig T; Murthy R; Shivakumar HN; Vanaja K; Kumar PC; Repka MA
    Int J Pharm; 2015 Jun; 487(1-2):167-76. PubMed ID: 25888797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.
    Tan Q; Zhang L; Liu G; He D; Yin H; Wang H; Wu J; Liao H; Zhang J
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1364-71. PubMed ID: 22994163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles.
    Amelian A; Wasilewska K; Wesoły M; Ciosek-Skibińska P; Winnicka K
    Saudi Pharm J; 2017 Dec; 25(8):1144-1150. PubMed ID: 30166902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
    Matsui R; Uchida S; Namiki N
    Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of a quality-by-design approach for utilizing sodium stearyl fumarate as a taste-masking agent in dextromethorphan hydrobromide orally disintegrating tablets.
    Mahrous GM; Ibrahim MA; Mostafa HF; Elzayat EM
    Pharm Dev Technol; 2019 Jul; 24(6):711-719. PubMed ID: 30714850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet.
    Hesari Z; Shafiee A; Hooshfar S; Mobarra N; Mortazavi SA
    Iran J Pharm Res; 2016; 15(4):677-686. PubMed ID: 28243264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet.
    Shah PP; Mashru RC
    J Pharm Pharmacol; 2008 Oct; 60(10):1279-85. PubMed ID: 18812020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fabrication of extended-dissolution divalproex tablets: a green solvent-free granulation technique.
    Khaled A; Abdel-Hamid S; Nasr M; Sammour OA
    Drug Dev Ind Pharm; 2020 Jun; 46(6):975-987. PubMed ID: 32362159
    [No Abstract]   [Full Text] [Related]  

  • 49. Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology.
    Alshehri SM; Park JB; Alsulays BB; Tiwari RV; Almutairy B; Alshetaili AS; Morott J; Shah S; Kulkarni V; Majumdar S; Martin ST; Mishra S; Wang L; Repka MA
    J Drug Deliv Sci Technol; 2015 Jun; 27():18-27. PubMed ID: 25914727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prediction of the palatability of orally disintegrating tablets by an electronic gustatory system.
    Nakamura H; Uchida S; Sugiura T; Namiki N
    Int J Pharm; 2015 Sep; 493(1-2):305-12. PubMed ID: 26216412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Orally disintegrating systems: innovations in formulation and technology.
    Goel H; Rai P; Rana V; Tiwary AK
    Recent Pat Drug Deliv Formul; 2008; 2(3):258-74. PubMed ID: 19075912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
    Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
    Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
    Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
    Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates.
    Preis M; Grother L; Axe P; Breitkreutz J
    Int J Pharm; 2015 Aug; 491(1-2):8-16. PubMed ID: 26051543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lean production of taste improved lipidic sodium benzoate formulations.
    Eckert C; Pein M; Breitkreutz J
    Eur J Pharm Biopharm; 2014 Oct; 88(2):455-61. PubMed ID: 24859305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is rat a good model for assessment of particulate-based taste-masked formulations?
    Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
    Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulation design of an oral, fast-disintegrating dosage form containing taste-masked particles of famotidine.
    Mizumoto T; Tamura T; Kawai H; Kajiyama A; Itai S
    Chem Pharm Bull (Tokyo); 2008 Jul; 56(7):946-50. PubMed ID: 18591807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
    Strickley RG
    J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design.
    Özyılmaz ED; Comoglu T
    Drug Dev Ind Pharm; 2022 Nov; 48(11):667-681. PubMed ID: 36454038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HME-assisted formulation of taste-masked dispersible tablets of cefpodoxime proxetil and roxithromycin.
    Patil PS; Suryawanshi SJ; Patil SS; Pawar AP
    J Taibah Univ Med Sci; 2024 Apr; 19(2):252-262. PubMed ID: 38616800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.